2024Plos Pathogens20 (9) : e1012569
Multifaceted activation of STING axis upon Nipah and measles virus-induced syncytia formation
Amurri L, Dumont C, Pelissier R, Reynard O, Mathieu C, Spanier J, Pályi B, Déri D, Karkowski L, Gonzalez C, Skerra J, Kis Z, Kalinke U, Horvat B, Iampietro M
2024Journal of Neuroinflammation21 (1) : 264
MAVS signaling shapes microglia responses to neurotropic virus infection
Gern O, Pavlou A, Mulenge F, Busker L, Ghita L, Aringo A, Costa B, Spanier J, Waltl I, Stangel M, Kalinke U
2024Neurobiology of Disease205 : 106773
Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins
Hartke A, Schreiber C, Lau K, Wiesweg I, Waltl I, Kalinke U, Richter F, Käufer C
2024Jhep Reports : Innovation in Hepatology6 (3) : 100989
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
Gömer A, Dinkelborg K, Klöhn M, Jagst M, Wißing M, Frericks N, Nörenberg P, Behrendt P, Cornberg M, Wedemeyer H, Steinmann E, Maasoumy B, Todt D
2024The Journal of Antimicrobial Chemotherapy79 (4) : 810-814
Identification of a CTX-M-255 β-lactamase containing a G239S substitution selectively conferring resistance to penicillin/β-lactamase inhibitor combinations
Andreasen M, Rick T, Alexandersen N, Hansen K, Pedersen M, Warweitzky J, Botelho C, Häussler S, Jelsbak L, Schønning K
2024Nature Communications15 (1) : 1745
Human cytomegalovirus exploits STING signaling and counteracts IFN/ISG induction to facilitate infection of dendritic cells
Costa B, Becker J, Krammer T, Mulenge F, Durán V, Pavlou A, Gern O, Chu X, Li Y, Čičin-Šain L, Eiz-Vesper B, Messerle M, Dölken L, Saliba A, Erhard F, Kalinke U
2025Arthritis & Rheumatology (hoboken, N.j.)77 (1) : 59-66
Toll-Like Receptor 8 is Expressed in Monocytes in Contrast to Plasmacytoid Dendritic Cells and Mediates Aberrant Interleukin-10 Responses in Patients With Systemic Sclerosis
Ehlers C, Thiele T, Biermann H, Traidl S, Bruns L, Ziegler A, Schefzyk M, Bartsch L, Kalinke U, Witte T, Graalmann T
2024Molecular Therapy. Methods & Clinical Development32 (4) : 101348
What's in a word? Defining "gene therapy medicines"
von Fritschen M, Janosz E, Blume C, Jägle U, Keating K, Schneider C
2024Nature Communications15 (1) : 1173
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor
Sake S, Zhang X, Rajak M, Urbanek-Quaing M, Carpentier A, Gunesch A, Grethe C, Matthaei A, Rückert J, Galloux M, Larcher T, Le Goffic R, Hontonnou F, Chatterjee A, Johnson K, Morwood K, Rox K, Elgaher W, Huang J, Wetzke M, Hansen G, Fischer N, Eléouët J, Rameix-Welti M, Hirsch A, Herold E, Empting M, Lauber C, Schulz T, Krey T, Haid S, Pietschmann T
2024Journal of Medical Virology96 (2) : e29455
Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons
Passos V, Henkel L, Wang J, Zapatero-Belinchón F, Möller R, Sun G, Waltl I, Schneider T, Wachs A, Ritter B, Kropp K, Zhu S, Deleidi M, Kalinke U, Schulz T, Höglinger G, Gerold G, Wegner F, Viejo-Borbolla A